“On the ropes,” Bayer seeks escape from costly Roundup litigation
Bayer executives have been warning in recent weeks that after losing billions of dollars to Roundup case settlements and jury awards, they may be ready to give up the fight.
Non-Hodgkin lymphoma
$2 billion Roundup jury verdict drives down Bayer shares as company seeks law change
By Carey Gillam
A Georgia jury verdict ordering Bayer AG to pay over $2 billion to a man suffering from cancer he blamed on his use of Roundup weed killer comes as that state’s governor weighs whether to sign into law a measure that would effectively bar such cases from going to trial in the future.
Monsanto Roundup trial win overturned by Oregon court
By Carey Gillam
An Oregon appeals court on Wednesday overturned a trial victory by Monsanto owner Bayer AG in a decision that adds to an ongoing debate over the company’s efforts to create a nationwide legal and legislative shield from lawsuits alleging Roundup weed killer causes cancer.
“We can’t sit back” – Amid climbing cancer rates, Iowa health officials eye farm chemicals
Faced with a startlingly high cancer rate in the key US farm state of Iowa, public health leaders are taking the politically precarious step of acknowledging that preventing disease necessitates cutting exposure to potentially cancer-causing chemicals, including those used in agriculture.
Citing new science, groups petition EPA to suspend glyphosate weed killer
By Carey Gillam
Citing new scientific research, a coalition of farmworker, public health and environmental advocates on Wednesday filed a legal petition with US regulators demanding they immediately suspend authorization for the controversial weed killing chemical called glyphosate.
Battle brewing over proposed US law that would protect pesticides
By Carey Gillam
Cancer patients are celebrating a string of courtroom victories after juries in three US states recently ordered Germany’s Bayer to pay more than $500 million in damages for failing to warn about the health risks of its Roundup herbicides. But the consumer wins come as proposed federal legislation backed by Bayer and the powerful agricultural industry could limit similar cases from ever going to trial in the future.
Conflict of interest alleged in Roundup case in Monsanto’s home town
By Carey Gillam
Lawyers representing a man who blames his cancer on exposure to Monsanto’s Roundup weed killer are crying foul over what they say are close personal ties between a lead Monsanto lawyer and a special magistrate helping oversee the Roundup litigation.
Bayer investors granted class-action status in lawsuit over Monsanto deal
A federal judge has given the green light for a class-action lawsuit to proceed against Bayer AG brought by investors unhappy with the company’s $63 billion purchase of Monsanto Co. in 2018.
New book details behind-the-scenes drama of Roundup trials
It’s been nearly eight years since the filing of the first US lawsuit alleging that Roundup weed killer and other herbicides made by Monsanto with a chemical called glyphosate can cause non-Hodgkin lymphoma (NHL). Fueled by findings from international cancer scientists, the allegations sprawled into nationwide litigation that ultimately included more than 100,000 plaintiffs, and unveiled long-hidden corporate secrets.
Monsanto accused of wrongly excluding non-US citizen from Roundup settlement
By Huanjia Zhang
(This story was originally published in Environmental Health News and is republished here with permission.) Monsanto Co. and its corporate parent Bayer are facing a federal lawsuit for civil rights violations after they allegedly excluded a farmworker from a Roundup cancer settlement because of her immigration status.